You are here: Industry Insights > Oxford University

News List

SII expects WHO emergency nod for AstraZeneca – Oxford University vaccine soon expresspharma
January 15, 2021
Poonawalla also said his company would start stockpiling millions of doses of the Novavax coronavirus vaccine candidate from around April.
Covishield can be available in first half of 2021 expresspharma
December 14, 2020
Serum Institute has currently applied with the DCGI for emergency authorization of Covishield in the country.
Britain presses on with AstraZeneca vaccine amid questions over trial data expresspharma
November 30, 2020
Britain gave AstraZeneca’s COVID-19 vaccine a vote of confidence on Friday when it asked its regulator to assess the shot for a rollout after experts raised questions about trial data and the company said it may run another study to gauge efficacy.
AZ/Oxford University’s COVID-19 vaccine shows average efficacy of 70% pharmatimes
November 24, 2020
AstraZeneca (AZ) and Oxford University’s COVID-19 vaccine candidate AZD1222 has scored an average efficacy rate of 70% in an interim analysis of phase II/III trials conducted in the UK and Brazil.
COVID-19 vaccine from AstraZeneca produces immune response in elderly expresspharma
November 20, 2020
AstraZeneca and Oxford University’s potential COVID-19 vaccine produced a strong immune response in older adults, data published on Thursday showed, with researchers expecting to release late-stage trial results by Christmas.
Interim data shows strong responses to AZ/Oxford Uni's COVID-19 vaccine pharmatimes
July 22, 2020
A vaccine against SARS-CoV-2 being developed by AstraZeneca and the University of Oxford is showing strong promise in clinical trials.
Serum to apply for local trials on Oxford’s vaccine in a week: CEO expresspharma
July 22, 2020
SII, the largest vaccine manufacturer in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it gets ready.
Oxford University coronavirus vaccine induces immune response: Lancet expresspharma
July 21, 2020
The findings are seen as promising, but experts feel it is too soon to know if this is enough to offer protection as larger trials get underway.
AstraZeneca Takes Next Steps Towards Broad Access to Oxford’s COVID-19 Vaccine contractpharma
June 09, 2020
Agreements with CEPI and Gavi and the Serum Institute of India will bring vaccine to low and middle-income countries and beyond.
AstraZeneca says it may consider exposing vaccine trial participants to virus expresspharma
June 01, 2020
The British drugmaker last week started phase 2 and 3 trials of the vaccine, looking to recruit around 10,000 adults and children in Britain.

Previous page 1 2 3 Next page